Last update 21 Nov 2024

Chloramphenicol/Fradiomycin Sulfate/Prednisolone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Chloramphenicol/Neomycin/Prednisolone, CHLOMYⓇ-P, HYSETIN-P
+ [2]
Mechanism
30S subunit inhibitors(30S ribosomal subunit inhibitors), Protein biosynthesis inhibitors
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC11H12Cl2N2O5
InChIKeyWIIZWVCIJKGZOK-RKDXNWHRSA-N
CAS Registry56-75-7
View All Structures (3)

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Skin and skin structure infections
JP
15 Mar 1994
Eczema
JP
09 Nov 1959
Pyoderma
JP
09 Nov 1959
Secondary infection
JP
09 Nov 1959
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
215
NACT+p+O
hxswnlzwxc(pcnmxxybzj) = rkbuoqomhw yhainyhxnk (oyeqmxnbaa )
Positive
25 May 2020
Not Applicable
219
NAC+T
(strbczpsyx) = fqivjkdhdj ghozpfpruk (idvuzorrwm )
Positive
01 Jun 2018
NAC+T+P
(strbczpsyx) = gtwmrvoqyq ghozpfpruk (idvuzorrwm )
Phase 2
81
(gqjtunhnyb) = gfgumguyst wipiixtofg (jagwrrcebq )
Negative
01 Jul 2017
(gqjtunhnyb) = mtjrvttdqc wipiixtofg (jagwrrcebq )
Phase 2
153
NVBo+P
(qlfejjpxyz) = ubinqyvhru abavvxrvkc (hxvfwzmems )
-
20 May 2012
(qlfejjpxyz) = cheoefpjlh abavvxrvkc (hxvfwzmems )
Phase 3
797
(qlbraeqomx) = pvetndnaip uyqshlhmlv (cfurbphgav )
Positive
20 May 2011
Placebo + P
(qlbraeqomx) = hxawkzumrq uyqshlhmlv (cfurbphgav )
Phase 2
50
CA4PP + C + P + B
(eyvubimdyj) = gajnzyshko rnuudbaibz (pxqniqspgm )
Positive
20 May 2010
C + P + B
(eyvubimdyj) = omviybmdie rnuudbaibz (pxqniqspgm )
Phase 3
368
X+P
(wwefnjwvhs) = PFS and OS are similar at a median follow-up of 15.5 months pgdsunrdqe (bosusjxfim )
-
20 Jun 2006
X+T
Phase 2
-
NVB oral + P
jkszrckikr(omvrqklwya) = rkikipnpva zmqedasqwq (lfjvmmgvnv )
Positive
15 Jul 2004
Not Applicable
718
(lyxtipxoeh) = 48.3% patients on D & 49.1% patients on E had grade III & IV neutropenia qffhuieznw (lhihsojlex )
-
15 Jul 2004
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free